Comments

Chemomab Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Chemomab Therapeutics (CMMB) operate in?

Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CMMBNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Chemomab Therapeutics (CMMB) Forecast

News Earnings Chemomab Therapeutics (CMMB) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Chemomab Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CMMB | Benzinga

Explore Chemomab Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CMMB.

Open	$1.37
Close	-
Volume / Avg.	29.70K / 125.28K
Day Range	$1.36 - $1.39
52 Wk Range	0.78 - 2.55
Market Cap	$25.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.41%
Days to Cover	1

Recent News

Chemomab Therapeutics' Touts Positive Data From Experimental Drug For Chronic Liver Disease

Chemomab's OLE study of nebokitug in PSC patients confirmed safety and showed improvements in liver stiffness, fibrosis biomarkers, and cholestasis markers.

Vandana Singh

Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Chemomab Therapeutics Reveals Data From Mid-Stage Study For Liver Disease Candidate, Stock Plunges On Capital Raise

Chemomab Therapeutics reports successful Phase 2 SPRING trial results for CM-101 in primary sclerosing cholangitis, showing safety and efficacy. Key findings include significant improvements in liver stiffness and pruritis, with a favorable safety profile.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.37
Close	-
Volume / Avg.	29.70K / 125.28K
Day Range	$1.36 - $1.39
52 Wk Range	0.78 - 2.55
Market Cap	$25.74M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	56
Short Interest	0.41%
Days to Cover	1

About Chemomab Therapeutics Ltd

Sector

Health Care

Industry

Biotechnology

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and develop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Chemomab Therapeutics (CMMB) stock?

You can purchase shares of Chemomab Therapeutics (NASDAQ:CMMB) through any online brokerage.

View our list of the best stock brokerages

Who are Chemomab Therapeutics (CMMB) competitors?

Other companies in Chemomab Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Imunon (NASDAQ:IMNN), Curis (NASDAQ:CRIS), Burning Rock Biotech (NASDAQ:BNR) and Coeptis Therapeutics (NASDAQ:COEP).

What is the forecast, or price target, for Chemomab Therapeutics (CMMB) stock?

Chemomab Therapeutics has a consensus price target of $8.00.

What is the current price for Chemomab Therapeutics (CMMB)?

The stock price for Chemomab Therapeutics (NASDAQ: CMMB) is $1.365 last updated May 29, 2025 at 3:28 PM EDT.

Does Chemomab Therapeutics (CMMB) pay a dividend?

There are no upcoming dividends for Chemomab Therapeutics.

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

Chemomab Therapeutics’s Q2 earnings are confirmed for Wednesday, August 20, 2025.

Is Chemomab Therapeutics (CMMB) going to split?

There is no upcoming split for Chemomab Therapeutics.

What sector and industry does Chemomab Therapeutics (CMMB) operate in?

Chemomab Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.